Jeffrey Bluestone - 03 May 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone
Issuer symbol
GILD
Transactions as of
03 May 2023
Transactions value $
$808,245
Form type
4
Filing time
04 May 2023, 18:13:30 UTC
Previous filing
18 May 2022
Next filing
09 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +1.89K 1.89K 03 May 2023 Common Stock 1.89K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $808K +10.2K $79.45 10.2K 03 May 2023 Common Stock 10.2K $79.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units vested immediately upon the grant date of May 3, 2023.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023.